ROCKET PHARMACEUTICALS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| Operating income | -$231.7 | -$273.2 | -$259.7 | -$224.3 | -$167.2 |
| Net income | -$223.1 | -$258.7 | -$245.6 | -$221.9 | -$169.1 |
| Cash Flow Statement | |||||
| Free cash flow | -$190.5 | -$215.6 | -$211.4 | -$186.5 | -$128.8 |
| Share repurchases | — | — | — | — | $0.0 |
Shares outstanding 109.8M · Free float 78.4%
Annual filing data through FY ended December 31, 2025; float as of September 27, 2026.